fuzzballl 12:33 pm on Tuesday, November 24, 2015

KBIO…crazy

New CEO seems pretty shady. Wonder how much he made on this deal. Incredible…

fuzzballl 12:34 pm on Tuesday, November 24, 2015

http://valuewalkposts.tumblr.com/post/133798480530/martin-shkrelis-kalobios-keeps-surging
Addy 12:49 pm on Tuesday, November 24, 2015

be careful, this guy led the politicians and FDA investigating his tactics on buying a drug and trying selling it 5000 times more than what it costs.
- fuzzballl 12:50 pm on Tuesday, November 24, 2015
  
  Yep..this is the paragraph in the article that caught my attention:
  
  Shkreli faces drug pricing criticism
  
  In his 20s after he’d set up his own hedge fund, Shkreli developed a reputation for using a stock-gossip website to savage the shares of biotech companies he was shorting. Shkreli would recommend shorting a biotech stock, betting the company’s share price would drop, and sure enough, it did. Shkreli is the head of privately-held Turing Pharmaceuticals, which was criticized in September for buying the rights to a parasitic infection treatment called Daraprim and then raising its price to $750 per pill from $13.50 a pill.
  - Addy 12:57 pm on Tuesday, November 24, 2015
    
    guys like him are damaging the reputation of some, just some, of the drug companies. By the way, this is my opinion, 90% CEOs are crooks